Accessibility Menu
 
Endra Life Sciences logo

Endra Life Sciences

(NASDAQ) NDRA

Current Price$5.50
Market Cap$6.93M
Since IPO (2017)-100%
5 Year-100%
1 Year+74%
1 Month+1%

Endra Life Sciences Financials at a Glance

Market Cap

$6.93M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.30M

EPS (TTM)

$-8.15

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$5.50

Volume

46

Open

$5.42

Previous Close

$5.50

Daily Range

$5.41 - $5.50

52-Week Range

$2.92 - $11.96

NDRA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Endra Life Sciences

Industry

Healthcare Equipment and Supplies

Employees

11

CEO

Alexander Y. Tokman

Headquarters

Ann Arbor, MI 48105-1570, US

NDRA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-413%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.93M

Shares Outstanding

1.27M

Volume

46

Avg. Volume

105.32K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.76M

EBITDA

$5.61M

Operating Cash Flow

$5.18M

Capital Expenditure

$17.28K

Free Cash Flow

$5.20M

Cash & ST Invst.

$762.37K

Total Debt

$492.35K

Endra Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$39.72K

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.93M

N/A

Market Cap/Employee

$330.22K

N/A

Employees

21

N/A

Net Income

$1.31M

-26.5%

EBITDA

$2.13M

-49.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$104.74K

-107.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$327.25K

-29.0%

Short Term Debt

$133.95K

+6.2%

Return on Assets

-2.12%

N/A

Return on Invested Capital

-2.48%

N/A

Free Cash Flow

$1.12M

+14.6%

Operating Cash Flow

$1.12M

+13.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$1.98+2.06%
BBLGBone Biologics Corporation
$1.22-0.81%
BGMSBio Green Med Solution, Inc.
$0.97-1.60%
NAOVNanoVibronix, Inc.
$1.90+1.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About NDRA

What is the current price of Endra Life Sciences?

Endra Life Sciences is trading at $5.50 per share.

What is the 52-week range for Endra Life Sciences?

Over the past 52 weeks, Endra Life Sciences has traded between $2.92 and $11.96.

How much debt does Endra Life Sciences have?

As of the most recent reporting period, Endra Life Sciences reported total debt of $461,206.

How much cash does Endra Life Sciences have on hand?

Endra Life Sciences reported $356,462 in cash and cash equivalents in its most recent financial results.

What is Endra Life Sciences’s dividend yield?

Endra Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.